C4 Therapeutics Inc (CCCC) — Free Cash Flow Generation Index

Latest as of June 2019: 0.98x

C4 Therapeutics Inc (CCCC) has a Free Cash Flow Generation Index of 0.98x as of June 2019. Free cash flow of $36.27 Million represents 1% of operating cash flow ($36.91 Million). Read C4 Therapeutics Inc (CCCC) financial obligations for a breakdown of total debt and financial obligations.

FCF Generation Index

0.98x
Free Cash Flow / Operating CF

Free Cash Flow

$36.27 Million
USD

Operating Cash Flow

$36.91 Million
USD

Capital Expenditures

$641.00K
USD

C4 Therapeutics Inc Free Cash Flow Generation Index (2019–2019)

Historical FCF Generation Index trend for C4 Therapeutics Inc across 1 annual periods. Explore capital reinvestment ratio of C4 Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for C4 Therapeutics Inc (2019–2019)

Year-by-year Free Cash Flow Generation Index for C4 Therapeutics Inc. For the full company profile including market capitalisation, see CCCC market cap.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2019 0.98x $54.27 Million $55.61 Million $1.35 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).